Early Life
Christoph Boehringer's family has deep roots in the pharmaceutical industry. The foundation of their wealth was laid in 1885 when Albert Boehringer purchased a small factory in Ingelheim am Rhein, Germany. Originally producing tartaric acid for the food industry, the company quickly pivoted towards pharmaceutical production, marking the beginning of what would become Boehringer Ingelheim.
Rise to Success
The company's success was significantly boosted by a groundbreaking discovery in 1893, when the company found a way to mass-produce lactic acid, which led to significant financial gains. Over the years, Boehringer Ingelheim expanded and evolved. The company is now one of the largest pharmaceutical companies in the world. The Boehringer/von Baumbach family, including Christoph Boehringer, continues to own and operate the company, maintaining its status as a privately-held entity.
Key Business Strategies
Boehringer Ingelheim focuses on research, development, and manufacturing of innovative healthcare products in human and animal health. The company emphasizes long-term commitment and sustainability across its value chain. Key products such as Jardiance, a medication for type 2 diabetes, have been major revenue drivers. The company has also invested significantly in research and development.
Philanthropy
While specific amounts are not available through a real-time search, Boehringer Ingelheim is known for its commitment to social responsibility and philanthropy. The company strives to improve the health of humans and animals for generations.
